Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • Clinical trial reveals promising outcomes for children with paediatric autoimmune neuropsychiatric disorders
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Clinical trial reveals promising outcomes for children with paediatric autoimmune neuropsychiatric disorders
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • Clinical trial reveals promising outcomes for children with paediatric autoimmune neuropsychiatric disorders
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • Clinical trial reveals promising outcomes for children with paediatric autoimmune neuropsychiatric disorders
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • Clinical trial reveals promising outcomes for children with paediatric autoimmune neuropsychiatric disorders
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    • News

  • Bioxyne leads the way as Australia’s first manufacturer of pharmaceutical cannabis gummies
    Bioxyne leads the way as Australia’s first manufacturer of pharmaceutical cannabis gummies
    • News

  • Actinogen’s Phase 2a clinical trial for depression treatment fails to meet primary endpoint, shares tank
    Actinogen’s Phase 2a clinical trial for depression treatment fails to meet primary endpoint, shares tank
    • News

  • Fintech lender Plenti sees its loan portfolio grow to $1.67 billion, sells off bad debts
    • News

    Fintech lender Plenti sees its loan portfolio grow to $1.67 billion, sells off bad debts

    The Australian housing market has left people in limbo with mortgage pressures forcing them to pinch pennies. As they cast around for low-cost lenders, fintech loan providers like Plenti (ASX: PLT) are enjoying their time in the spotlight.  In Q2 FY23, Plenti’s loan portfolio increased to $1.67 billion, 51% above Q2 FY22 and 8% above

    Read More
    Public
  • JB Hi-Fi sales propel to $5.3 billion as customers return to in-store shopping
    • News

    JB Hi-Fi sales propel to $5.3 billion as customers return to in-store shopping

    It was the quarter to be in retail as Boxing Day and Christmas sales ushered in significant sales and the eradication of Covid lockdowns enabling Aussies to return to in-store shopping.  Putting Covid on the back burner, 2023 looks pretty for retail businesses eagerly awaiting this return. Plus, with household budgets squeezed due to rising

    Read More
    Public
  • The Market Herald appoints Gumtree boss Tommy Logtenberg as Interim CEO
    • News

    The Market Herald appoints Gumtree boss Tommy Logtenberg as Interim CEO

    Following the unfolding of the Jag Sanger drama, media house and classified ads agency The Market Herald (ASX: TMH) is attempting to move on from the awkwardness with the appointment of new Interim CEO Tommy Logtenberg. Logtenberg is also the CEO and CFO of classified ads company Gumtree, which was acquired by The Market Herald

    Read More
    Public
  • Oliver’s reports $2.6 million in sales as Aussies shift to healthier eating habits
    • News

    Oliver’s reports $2.6 million in sales as Aussies shift to healthier eating habits

    Aussies have entered the new year on a healthy note as nutritional quick-service eatery Oliver’s Real Food (ASX: OLI) reported sales of $2.6 million in December 2022.  Its unaudited earnings for December were $231k on sales of $2.6 million with the Oliver’s responding to the ASX’s regulatory requirements asking the Company to report monthly cash

    Read More
    Public
  • Little Green Pharma’s roll of fortune – looking ahead to growing European Pipeline
    • News

    Little Green Pharma’s roll of fortune – looking ahead to growing European Pipeline

    Little Green Pharma (ASX: LGP) has been on a roll this quarter. Increasing cash receipts by 35% from $4.4 million to $6 million, the Company has made strides in its cannabis operations. The influx of revenue was thanks to the first shipment of new strains from Denmark, which earned more than $0.5 million over five

    Read More
    Public
  • Aerometrex bags $2 million Australian Government contract for its LiDAR tech
    • News

    Aerometrex bags $2 million Australian Government contract for its LiDAR tech

    When was the last time you used Google or Apple maps? Perhaps just yesterday as you cast around for that eatery or maybe even on your way to work. With Google maps, you can zoom in and out of areas, discover precise locations and even get recommendations on how to get to your destination through

    Read More
    Public
  • Acusensus kicks off ASX listing with government agency contracts and tenders
    • News

    Acusensus kicks off ASX listing with government agency contracts and tenders

    Commencing trading on the ASX today, road safety technology company Acusensus (ASX: ACE) is officially the new kid on the block. Kicking off their public profile with a bang, their long line up of future projects with government agencies may see them quickly added to investor watchlists.   The Company proudly shared some exciting overview and

    Read More
    Public
  • Limeade joins tech layoff trend, set to layoff 15% of its workforce
    • News

    Limeade joins tech layoff trend, set to layoff 15% of its workforce

    Tech giants, from Amazon to Meta and more, have been laying off thousands of staff, cementing rumours of an ongoing recession. The economic downturn is not limited to the US, though. Ironically enough, Australian employee well-being company Limeade (ASX: LME) is laying off 15 per cent of its employees as part of its cost-cutting initiatives.

    Read More
    Public
  • Mayne Pharma defers shareholder dividends by two months, retains focus on women’s health products
    • News

    Mayne Pharma defers shareholder dividends by two months, retains focus on women’s health products

    Once one of the biggest names in the pharmaceuticals industry, Mayne Pharma (ASX: MYX) has suffered a string of bad luck—or bad decisions—since 2015. It has consistently been reporting losses to the tune of millions. In FY22, it reported a loss of about $260 million. Shareholders have been eagerly standing by for a financial miracle

    Read More
    Public
  • Bring life to old tyres: Entyr granted patent to recycle rubber tyres
    • News

    Bring life to old tyres: Entyr granted patent to recycle rubber tyres

    Entyr Limited (ASX: ETR) has achieved a major breakthrough in waste management with its patented thermal desorption reactor process. This revolutionary technology is designed to safely and effectively dispose of end-of-life tyres and help resolve one of the most pressing environmental issues around the world.  Leading the way in providing solutions for tyre waste management,

    Read More
    Public
  • «
  • ‹
  • 134
  • 135
  • 136
  • 137
  • 138
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.